| Pharmaceutical Information |
| Drug Name |
Rescinnamine |
| Drug ID |
BADD_D01925 |
| Description |
Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug. It is an alkaloid obtained from _Rauwolfia serpentina_ and other species of _Rauwolfia_. |
| Indications and Usage |
For the treatment of hypertension. |
| Marketing Status |
Discontinued |
| ATC Code |
C02AA01 |
| DrugBank ID |
DB01180
|
| KEGG ID |
D00198
|
| MeSH ID |
C084826
|
| PubChem ID |
5280954
|
| TTD Drug ID |
D0G8NJ
|
| NDC Product Code |
Not Available |
| Synonyms |
rescinnamine | Moderil |
|
| Chemical Information |
| Molecular Formula |
C35H42N2O9 |
| CAS Registry Number |
24815-24-5 |
| SMILES |
COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C(=C6)OC)O
C)OC |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
